Advising Health Care Boards on Achieving Fiduciary “Effectiveness”
This Featured Article is co-published with The Governance Institute.
- April 29, 2022
- Michael W. Peregrine , McDermott Will & Emery LLP
- Anne M. Murphy , ArentFox Schiff LLP
Constituents, regulators, and observers of corporate governance are increasingly focused on the “effectiveness” of board performance: the extent to which its existing governance practices and orientation are consistent with (or exceed) industry standards and recognized principles. This is especially the case in an industry as diverse and challenging as health care, where governance conduct is continuously being pressured by events and perceptions.
You must be logged in to access this content.